Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation
- PMID: 1974499
- DOI: 10.1007/BF01409477
Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation
Abstract
The effects of labetalol and carvedilol on local cutaneous microvascular perfusion and calculated local cutaneous microvascular resistance were investigated in anesthetized rats at submaximal doses that produced equivalent reductions in blood pressure and heart rate. Labetalol decreased cutaneous perfusion (-25% +/- 3%) without significantly affecting cutaneous vascular resistance (-6% +/- 3%). In marked contrast, carvedilol dramatically increased cutaneous perfusion (+64% +/- 9%) and significantly reduced cutaneous vascular resistance (-57% +/- 3%). These results suggest that carvedilol and labetalol possess differences in the mechanisms by which they produce vasodilation in vivo.
Similar articles
-
Local cutaneous hemodynamic effects of carvedilol and labetalol in the anesthetized rat.Eur J Pharmacol. 1990 Feb 6;176(2):237-40. doi: 10.1016/0014-2999(90)90535-e. Eur J Pharmacol. 1990. PMID: 2311669
-
Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.J Cardiovasc Pharmacol. 1987;10 Suppl 11:S69-75. J Cardiovasc Pharmacol. 1987. PMID: 2454372 Clinical Trial.
-
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.Drugs. 1988;36 Suppl 6:37-47. doi: 10.2165/00003495-198800366-00008. Drugs. 1988. PMID: 2908303 Clinical Trial.
-
The vasodilatory beta-blockers.Curr Hypertens Rep. 2007 Aug;9(4):269-77. doi: 10.1007/s11906-007-0050-2. Curr Hypertens Rep. 2007. PMID: 17686376 Review.
-
Vasodilatory action of carvedilol.J Cardiovasc Pharmacol. 1992;19 Suppl 1:S5-11. doi: 10.1097/00005344-199219001-00003. J Cardiovasc Pharmacol. 1992. PMID: 1378150 Review.
Cited by
-
Clinical pharmacology of carvedilol.Clin Investig. 1992;70 Suppl 1:S27-36. doi: 10.1007/BF00207608. Clin Investig. 1992. PMID: 1350481 Clinical Trial.
-
Pharmacological profile of beta-adrenoceptor blockers with vasodilating properties, especially carvedilol--rationale for clinical use.Clin Investig. 1992;70 Suppl 1:S20-6. doi: 10.1007/BF00207607. Clin Investig. 1992. PMID: 1350480 Review.
-
Long-term hemodynamic effects of antihypertensive treatment.Clin Investig. 1992;70 Suppl 1:S58-64. doi: 10.1007/BF00207613. Clin Investig. 1992. PMID: 1350486
-
Clinical pharmacokinetics and pharmacodynamics of carvedilol.Clin Pharmacokinet. 1994 May;26(5):335-46. doi: 10.2165/00003088-199426050-00002. Clin Pharmacokinet. 1994. PMID: 7914479 Review.
-
Carvedilol and the kidney.Clin Investig. 1992;70 Suppl 1:S127-31. doi: 10.1007/BF00207623. Clin Investig. 1992. PMID: 1350479 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources